Management ChangeJun 17, 2026, 06:07 AM
Alterity Therapeutics Files 6-K with Director Interest Changes
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on June 17, 2026, reporting changes in director's interests. The filing, signed by Chairman Julian Babarczy, incorporates by reference into several registration statements.
Key Highlights
- Alterity Therapeutics Limited filed a Form 6-K on June 17, 2026.
- The filing includes 'Change of Director's Interest Notice x 2' as Exhibit 99.1.
- Julian Babarczy signed the report as Chairman on June 17, 2026.
Price Impact
More from ATHE